2016-03-11T00:00:00.000-05:00
dividend yield,0.233454
strong buy rating,0.484282
price target,0.373954
investment analysts,0.38615
Vanguard Group Inc.,0.387462
Company LLC,0.327009
market capitalization,-0.325809
consensus price target,0.43038
hold rating,0.38615
Robert W. Baird,0.272469
P/E ratio,-0.325809
InvestorPlace Broker Center,0.555736
MarketBeat Ratings reports,-0.220411
Janus Capital Management,0.230072
biopharmaceutical company,0.384087
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
average rating,-0.404878
OppenheimerFunds Inc.,0.329172
ex-dividend date,-0.378179
research note,0.317527
Gilead Sciences Inc.,0.555178
Morgan Stanley,0.346119
Gilead Sciences stock,-0.242611
equities research analysts,-0.324164
average price,-0.235316
shares,0.096654
concise daily summary,0.447788
Gilead Sciences,0.296346
stock broker,0.245696
Boston Partners,0.369015
chronic hepatitis,-0.646567
EVP Paul Rutherford,-0.242611
quarter,-0.403763
